Pembrolizumab 2 mg/kg Q3W for previously treated, PD-L1-positive advanced NSCLC Meeting Abstract
| Authors: | Fløtten, Ø.; Garon, E. B.; Arkenau, H. T.; Hui, R.; Gandhi, L.; Felip, E.; Lena, H.; Cappuzzo, F.; Horn, L.; Gubens, M.; Zhang, J.; Lubiniecki, G.; Im, E.; Hellmann, M. |
| Abstract Title: | Pembrolizumab 2 mg/kg Q3W for previously treated, PD-L1-positive advanced NSCLC |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | pembrolizumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S270 |
| Language: | English |
| ACCESSION: | WOS:000370365101025 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30011-9 |
| Notes: | Meeting Abstract: MINI03.03 -- Source: Wos |
